Pharmacopoeal Name : Teneligliptin 20 mg & Metformin 500 mg Tablets Brand Name : GLIPTON-M1 Tablets Composition : Each uncoated Bilayered Tablet contains : Teneligliptin Hydrobromide Hydrate I.P. Eq. to Teneligliptin 20 mg. Metformin Hydrochloride I.P. 500 mg. (As Extended Release) Excipients Q. S. Colour : Ferric Oxide Yellow (In Teneligliptin Layer) Therapeutic Uses : Teneligliptin increases Insulin Release & decreases Glycogen Levels in the circulation in a Glucose dependent Manner. Metformin improves Glucose Tolerance in Patients with Type-II Diabetes. It decreases hepatic glucose production, decreases intestinal absorption of Glucose & improves Insulin sensitivity. Unique Features : Very useful in patients with Cardio-vascular diseases. Metformin intolerable patients. Elderly diabetic Patients. Type-II Diabetes Packing Unit : Box Pack of 10 x 15 Tablets Blister strips

Pharmacopoeal Name : Metformin 500 mg Sustained Release Tablets Brand Name : GLYCOPROT-500 SR Tablets Composition : Each uncoated Tablet contains: Metformin Hydrochloride I.P. 500 mg. (In Sustained Release form) Excipients Q. S. Therapeutic Uses : Metformin is the 1st Line Anti Hyperglycamic most commonly prescribed agent in Type-II Diabetes Patients Metformin improves sensitivity & Corrects impaired Glucose Metabolism. Metformin decreases Level of Total Cholesterol & LDL Level, maintaining HDL Levels. Unique Features : Type-II Diabetes 1st Line Treatment. Adult Monotherapy for Type-II Diabetes. Obese Patients of Type-II Diabetes Packing Unit : Box Pack of 10 x 15 Tablets Blister strips

PENTOX-DSR Capsules : Pantoprazole Sodium Enteric Coated And Domperidone Sustained Release Capsules Pharmacopoeal Name : Pantoprazole & Domperidone Capsules Brand Name : PENTOX-DSR Capsules Composition : Each hard gelatin capsule contains: Pantoprazole Sodium Sesquihydrate IP Eq. to Pantoprazole 40 mg. (as enteric coated pellets) Domperidone IP 30 mg. (as sustained release Pellets) Excipients Q.S. Therapeutic Uses : Anti-ulcerant, reduces Acidity, controls nausea & vomiting. Acidity related disorders like peptic ulcer, duodenal & gastric ulcer, reflux oesophagitis etc. Packing Unit : Box Pack of 10 x 10 Capsules

ESOTID-DSR Capsules : Esomeprazole 40 mg (As Enteric Coated Pellets) & Domperidone 30 mg (As Sustained Release Pellets) Pharmacopoeal Name : Esomaprazole E.C. & Domperidone S.R. Capsules Brand Name : ESOTID-DSR Capsules Composition : Each hard gelatin Capsule contains : Esomeprazole I.P. 40 mg. (As enteric coated Pellets) Domperidone I.P. 30 mg. (As Sustained Release Pellets) Excipients Q. S. Approved Colours used in empty hard gelatin Capsule shells & Pellets. Therapeutic Uses : Anti-ulcerant, reduces Acidity, controls nausea & vomiting. Acidity related disorders like peptic ulcer, duodenal & gastric ulcer, reflux oesophagitis etc. Packing Unit : Outer Box Pack of 10 x 10 Capsules

RABETID-LSR Capsules : Rabeprazole & Levosulpride SR Capsules Pharmacopoeal Name : Rabeprazole Sodium Enteric coated Levosulpride SR Capsules Brand Name : RABETID-LSR Capsules Composition : Each hard gelatin capsule contains : Rabeprazole Sodium IP 20 mg. (As Enteric coated Pellets) Levosulpride 75 mg. (As Sustained Release Pellets) Excipients Q.S. Therapeutic Uses : Bronchial Asthma Sinusitis Dried Rhinitis Chronic Obstructive Pulmonary Disorders Acute Chronic Bronchitis Seasonal / Perennial Rhinitis Packing Unit : Box Pack of 10 x 10 Capsules

RABETID DSR Capsules : Rabeprazole & Domperidone Capsules. Pharmacopoeal Name : Rabeprazole Sodium Enteric coated & Domperidone SR Capsules Brand Name : RABETID-DSR Capsules Composition : Each hard gelatin capsule contains : Rabeprazole Sodium IP 20 mg. (As Enteric coated Pellets) Domperidone 30 mg. (As Sustained Release Pellets) Excipients Q.S. Therapeutic Uses : Anti-ulcerant, reduces Acidity, controls nausea & vomiting. Acidity related disorders like peptic ulcer, duodenal & gastric ulcer, reflux oesophagitis etc. Packing Unit : Box Pack of 10 x 10 Capsules

Each film coated Sustained Release Tablet contains : Aceclofenac I.P. 200 mg. Colours : Titanium Dioxide I.P. & Ponceau-4R

Pharmacopoeal Name : Metformin 500 mg & Glimepiride 2 mg Tablets Brand Name : GLYCOPROT-G2 Tablets Composition : Each uncoated Bilayered Tablet contains : Metformin Hydrochloride I.P. 500 mg (In Prolonged Release form) Glimepiride I.P. 2 mg. Excipients Q. S. Colour : Sunset Yellow FCF Therapeutic Uses : Metformin is the 1st Line Anti Hyperglycamic most commonly prescribed agent in Type-II Diabetes Patients Metformin improves sensitivity & Corrects impaired Glucose Metabolism. Metformin decreases Level of Total Cholesterol & LDL Level, maintaining HDL Levels. Glimepiride improves peripheral glucose uptake & decreases endogenous Glucose Production Effective & well tolerated oral anti-hyperglycemic drug. Improves Insulin Resistance. Unique Features : Type-II Diabetes Preferred Treatment. Type-II Diabetes with or without Obesity. Packing Unit : Box Pack of 10 x 15 Tablets Blister strips

Pharmacopoeal Name : Metformin 500 mg & Glimepiride 1 mg Tablets Brand Name : GLYCOPROT-G1 Tablets Composition : Each uncoated Bilayered Tablet contains : Metformin Hydrochloride I.P. 500 mg (In Prolonged Release form) Glimepiride I.P. 1 mg. Excipients Q. S. Colour : Red Oxide of Iron Therapeutic Uses : Metformin is the 1st Line Anti Hyperglycamic most commonly prescribed agent in Type-II Diabetes Patients Metformin improves sensitivity & Corrects impaired Glucose Metabolism. Metformin decreases Level of Total Cholesterol & LDL Level, maintaining HDL Levels. Glimepiride improves peripheral glucose uptake & decreases endogenous Glucose Production Effective & well tolerated oral anti-hyperglycemic drug. Improves Insulin Resistance. Unique Features : Type-II Diabetes Preferred Treatment. Type-II Diabetes with or without Obesity. Packing Unit : Box Pack of 10 x 15 Tablets Blister strips